Tirzepatide (30mg)
Dual GIP/GLP-1 receptor agonist researched for metabolic regulation.
Product Details
| Product | Tirzepatide (30mg) |
|---|
| Size | 30mg |
|---|
| Category | Metabolic & Appetite Research |
|---|
| Price | 64.00 USD |
|---|
| Availability | In Stock |
|---|
| Purity | ≥99% (third-party tested) |
|---|
| CAS Number | 2023788-19-2 |
|---|
| Molecular Weight | 4813.45 g/mol |
|---|
| Form | Lyophilized powder (vial) |
|---|
| Storage | Refrigerate at 2–8°C after reconstitution |
|---|
| Brand | Helix Amino |
|---|
Research Notes
Research has shown dual incretin receptor agonism producing superior glycemic control and body weight reduction compared to selective GLP-1 agonists alone. Studies demonstrate enhanced insulin sensitivity, reduced appetite, and improved metabolic markers through combined GIP and GLP-1 pathway activation.
View Certificate of Analysis (COA) · View Safety Data Sheet (SDS)
Disclaimer: All products are for in-vitro laboratory research use only. Not for human consumption. Not evaluated or approved by the FDA.